In our first experiments we investigated the ability of CML cells to generate FANCD2 nuclear foci, a central process in the FA pathway (see review in[20]), both during cell proliferation and after exposure to DNA cross-linking agents. Here, FANCD2 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.